Bacterial carrier-mediated drug delivery systems: a promising strategy in cancer therapy

Cancer is a major killer threatening modern human health and a leading cause of death worldwide. Due to the heterogeneity and complexity of cancer, traditional treatments have limited effectiveness. To address this problem, an increasing number of researchers and medical professionals are working to...

Full description

Saved in:
Bibliographic Details
Main Authors: Sizuo Yan, Yu Gan, Huizhe Xu, Haozhe Piao
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fbioe.2024.1526612/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841555166720950272
author Sizuo Yan
Yu Gan
Huizhe Xu
Huizhe Xu
Haozhe Piao
Haozhe Piao
author_facet Sizuo Yan
Yu Gan
Huizhe Xu
Huizhe Xu
Haozhe Piao
Haozhe Piao
author_sort Sizuo Yan
collection DOAJ
description Cancer is a major killer threatening modern human health and a leading cause of death worldwide. Due to the heterogeneity and complexity of cancer, traditional treatments have limited effectiveness. To address this problem, an increasing number of researchers and medical professionals are working to develop new ways to treat cancer. Bacteria have chemotaxis that can target and colonize tumor tissue, as well as activate anti-tumor immune responses, which makes them ideal for biomedical applications. With the rapid development of nanomedicine and synthetic biology technologies, bacteria are extensively used as carriers for drug delivery to treat tumors, which holds the promise of overcoming the limitations of conventional cancer treatment regimens. This paper summarizes examples of anti-cancer drugs delivered by bacterial carriers, and their strengths and weaknesses. Further, we emphasize the promise of bacterial carrier delivery systems in clinical translation.
format Article
id doaj-art-5ef081afc3164a18ba63ebbcdaf12e14
institution Kabale University
issn 2296-4185
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Bioengineering and Biotechnology
spelling doaj-art-5ef081afc3164a18ba63ebbcdaf12e142025-01-08T06:11:46ZengFrontiers Media S.A.Frontiers in Bioengineering and Biotechnology2296-41852025-01-011210.3389/fbioe.2024.15266121526612Bacterial carrier-mediated drug delivery systems: a promising strategy in cancer therapySizuo Yan0Yu Gan1Huizhe Xu2Huizhe Xu3Haozhe Piao4Haozhe Piao5Department of Neurosurgery, Liaoning Cancer Hospital and Institute, Cancer Hospital of China Medical University, Cancer Hospital of Dalian University of Technology, Shenyang, ChinaDepartment of Neurosurgery, Liaoning Cancer Hospital and Institute, Cancer Hospital of China Medical University, Cancer Hospital of Dalian University of Technology, Shenyang, ChinaInstitute of Cancer Medicine, Dalian University of Technology, Dalian, ChinaCentral Laboratory, Liaoning Cancer Hospital and Institute, Cancer Hospital of China Medical University, Cancer Hospital of Dalian University of Technology, Shenyang, ChinaDepartment of Neurosurgery, Liaoning Cancer Hospital and Institute, Cancer Hospital of China Medical University, Cancer Hospital of Dalian University of Technology, Shenyang, ChinaInstitute of Cancer Medicine, Dalian University of Technology, Dalian, ChinaCancer is a major killer threatening modern human health and a leading cause of death worldwide. Due to the heterogeneity and complexity of cancer, traditional treatments have limited effectiveness. To address this problem, an increasing number of researchers and medical professionals are working to develop new ways to treat cancer. Bacteria have chemotaxis that can target and colonize tumor tissue, as well as activate anti-tumor immune responses, which makes them ideal for biomedical applications. With the rapid development of nanomedicine and synthetic biology technologies, bacteria are extensively used as carriers for drug delivery to treat tumors, which holds the promise of overcoming the limitations of conventional cancer treatment regimens. This paper summarizes examples of anti-cancer drugs delivered by bacterial carriers, and their strengths and weaknesses. Further, we emphasize the promise of bacterial carrier delivery systems in clinical translation.https://www.frontiersin.org/articles/10.3389/fbioe.2024.1526612/fullbacteriabacterial derivativesdrug deliverybacteriotherapycancer
spellingShingle Sizuo Yan
Yu Gan
Huizhe Xu
Huizhe Xu
Haozhe Piao
Haozhe Piao
Bacterial carrier-mediated drug delivery systems: a promising strategy in cancer therapy
Frontiers in Bioengineering and Biotechnology
bacteria
bacterial derivatives
drug delivery
bacteriotherapy
cancer
title Bacterial carrier-mediated drug delivery systems: a promising strategy in cancer therapy
title_full Bacterial carrier-mediated drug delivery systems: a promising strategy in cancer therapy
title_fullStr Bacterial carrier-mediated drug delivery systems: a promising strategy in cancer therapy
title_full_unstemmed Bacterial carrier-mediated drug delivery systems: a promising strategy in cancer therapy
title_short Bacterial carrier-mediated drug delivery systems: a promising strategy in cancer therapy
title_sort bacterial carrier mediated drug delivery systems a promising strategy in cancer therapy
topic bacteria
bacterial derivatives
drug delivery
bacteriotherapy
cancer
url https://www.frontiersin.org/articles/10.3389/fbioe.2024.1526612/full
work_keys_str_mv AT sizuoyan bacterialcarriermediateddrugdeliverysystemsapromisingstrategyincancertherapy
AT yugan bacterialcarriermediateddrugdeliverysystemsapromisingstrategyincancertherapy
AT huizhexu bacterialcarriermediateddrugdeliverysystemsapromisingstrategyincancertherapy
AT huizhexu bacterialcarriermediateddrugdeliverysystemsapromisingstrategyincancertherapy
AT haozhepiao bacterialcarriermediateddrugdeliverysystemsapromisingstrategyincancertherapy
AT haozhepiao bacterialcarriermediateddrugdeliverysystemsapromisingstrategyincancertherapy